|
accutane,
bextra The FDA has been pushed to withdraw or put warnings
on two popular drugs. Accutane or Isotretinoin is a
popular acne medication coming under fire for causing depression
and whether it is safe to use during pregnancy. Bextra or
Valdecoxib is prescribed for arthritis and menstrual
cramping. Bextra's side effects include: potential
for increased risk of cardiovascular events,
gastrointestinal
bleeding and serious
skin reactions, some resulting in death.
On
April 7, 2005 the FDA announced that it has asked Pfizer, Inc.
to withdraw Bextra from the market "because the overall
risk versus benefit profile for the drug is unfavorable."
| FDA
INFORMATION |
| To read the
FDA's announcement withdrawing
Bextra. |
| Click
here to read the FDA
questions and answers about strengthened warnings on Bextra®
boxes. |
| To
report any unexpected adverse or serious events associated
with the use of Bextra® contact the FDA MedWatch program
on the internet or at 1-800-FDA-1088 |
bextra
site map
Bextra® is a non-steroidal anti-inflammatory drug
(NSAIDs), known as a COX-2 selective agent. It is
prescribed for inflammation and pain from arthritis or menstrual
cramping. Other drugs in this class include Celebrex® and
Vioxx®. Bextra® and Celebrex® are both marketed by
Pharmacia Corporation and Pfizer
and Vioxx® is manufactured by Merck. Doctors switched patients
from Vioxx® to Bextra® when Merck voluntarily removed it from the
market due studies showing an increased risk for heart attack
and stroke.
Autism
Education Materials for early intervention!
|
